144 related articles for article (PubMed ID: 19745077)
1. A monoclonal gammopathy in search of clinical significance: 57 years later.
Go RS; Doyle LM
Blood; 2009 Sep; 114(11):2355-6; author reply 2356-7. PubMed ID: 19745077
[No Abstract] [Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal gammopathy precedes multiple myeloma in most patients.
Weiss BM; Abadie J; Verma P; Howard RS; Kuehl WM
Blood; 2009 May; 113(22):5418-22. PubMed ID: 19234139
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA
Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
[TBL] [Abstract][Full Text] [Related]
5. [Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis].
Debus J; Lemaire P; Alani M; Farhi J; Rose J; Cussac V; Defasque S; Denizon N; Ghnaya H; Besançon-Bergelin A; Laribi K; Pineau-Vincent F
Ann Biol Clin (Paris); 2018 Aug; 76(4):451-457. PubMed ID: 30078781
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy: natural history studied with a retrospective approach.
Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy associated with monoclonal gammopathy.
Ravindran A; Go RS; Fervenza FC; Sethi S
Kidney Int; 2017 Mar; 91(3):691-698. PubMed ID: 27998645
[TBL] [Abstract][Full Text] [Related]
8. Polyneuropathies associated with plasma cell dyscrasias.
Kelly JJ
Semin Neurol; 1987 Mar; 7(1):30-9. PubMed ID: 3332445
[No Abstract] [Full Text] [Related]
9. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
[TBL] [Abstract][Full Text] [Related]
11. [Malignant transformation of monoclonal gammopathy of undetermined significance].
Decaux O; Avet-Loiseau H; Grosbois B
Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy and spurious hypophosphatemia.
Weisbord SD; Chaudhuri A; Blauth K; DeRubertis FR
Am J Med Sci; 2003 Feb; 325(2):98-100. PubMed ID: 12589234
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance: new insights.
Chen BH
CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
[No Abstract] [Full Text] [Related]
14. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
15. [The monoclonal gammapathy of uncertain meaning- a premyelomatosis?].
Kühn RA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):312-6. PubMed ID: 2428705
[TBL] [Abstract][Full Text] [Related]
16. Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
Kastritis E; Kanellias N; Theodorakakou F; Psimenou E; Gakiopoulou C; Marinaki S; Roussou M; Gavriatopoulou M; Migkou M; Fotiou D; Eleutherakis-Papaiakovou E; Malandrakis P; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2020 Dec; 61(13):3247-3250. PubMed ID: 32716220
[No Abstract] [Full Text] [Related]
17. [The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West].
Schaar CG; Ong F; Snijder S; Wijermans PW; Franck PF; Kluin-Nelemans JC
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1591-5. PubMed ID: 9763839
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta 1 and urinary excretion of pyridinium crosslinks: Two often overlooked risk factors for assessing risk of progression in patients with monoclonal gammopathy of undetermined significance.
Kapoor S
Haematologica; 2008 Mar; 93(3):e38. PubMed ID: 18310534
[No Abstract] [Full Text] [Related]
19. Monoclonal gammopathy-associated pure red cell aplasia.
Korde N; Zhang Y; Loeliger K; Poon A; Simakova O; Zingone A; Costello R; Childs R; Noel P; Silver S; Kwok M; Mo C; Young N; Landgren O; Sloand E; Maric I
Br J Haematol; 2016 Jun; 173(6):876-83. PubMed ID: 26999424
[TBL] [Abstract][Full Text] [Related]
20. Lymphoreticular malignancy and monoclonal gammopathy presenting as polymyalgia rheumatica.
Kalra L; Delamere JP
Br J Rheumatol; 1987 Dec; 26(6):458-9. PubMed ID: 3480012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
